Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection

An effective therapeutic vaccine for the treatment of chronic hepatitis C virus (HCV) infection, as an adjunct to newly developed directly-acting antivirals (DAA), or for the prevention of reinfection, would significantly reduce the global burden of disease associated with chronic HCV infection. A r...

Full description

Bibliographic Details
Main Authors:	Swadling, L, Halliday, J, Kelly, C, Brown, A, Capone, S, Ansari, M, Bonsall, D, Richardson, R, Hartnell, F, Collier, J, Ammendola, V, Del Sorbo, M, Von Delft, A, Traboni, C, Hill, A, Colloca, S, Nicosia, A, Cortese, R, Klenerman, P, Folgori, A, Barnes, E
Format:	Journal article
Language:	English
Published:	MDPI 2016

Highly-immunogenic virally-vectored T-cell vaccines cannot overcome subversion of the T-cell response by HCV during chronic infection

Similar Items